MobiHealth News December 4, 2023
Jessica Hagen

The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.

EndoQuest, an endoluminal robotics technology company, announced it closed a $42 million C-1 preferred financing round.

Existing investors CE Ventures Limited and McNair Interests Ltd. participated in the round, as did new investor Puma Venture Capital LLC.

WHAT IT DOES

The Houston-based company developed a flexible robotics surgery system to perform minimally invasive procedures in upper and lower gastrointestinal and other endoluminal areas. The platform allows for endoluminal and single-incision surgery through the body’s natural orifices or via a transumbilical incision.

EndoQuest plans to use the funds for growth, which includes scaling its commercialization efforts, achieving regulatory milestones and furthering...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Robotics/RPA, Technology, Trends
Less pain, quicker recoveries: 1 year of University Hospitals' robotics push
Here’s The Second Humanoid Robot To Get A Paying Job
CES 2025: 20 Tech Experts Predict Highlights And Trends
Study explores factors influencing acceptance of home-care robots
FHC #157: NVIDIA expects AI, robots to cure healthcare’s biggest problems

Share This Article